Back to search
FDAFDA · Food and drugs·Recall number Z-1109-2017

Cryptococcal Antigen Lateral Flow Assay (CrAg LFA), Reference # CR2003

Published February 8, 2017 · Recall initiated: December 27, 2016

Summary

FDA records medical device Class II recall Z-1109-2017, published February 8, 2017 and initiated December 27, 2016. Recalling firm: Immuno-Mycologics, Inc; Status: Terminated; Reported quantity: 630 units; Lot: 161028133653JH, 161003111544KH, and 161007105036JG. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The affected products have approximately a 91% specificity while the non-affected lots have approximately a 99% specificity. The recalling firm is aware of three customers who reported false positive results.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Immuno-Mycologics, Inc
Distributor
Nationwide throughout the US
Lot
161028133653JH, 161003111544KH, and 161007105036JG
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Cryptococcal Antigen Lateral Flow Assay (CrAg LFA), Reference # CR2003 recalled?

Yes. FDA published recall Z-1109-2017 on February 8, 2017. Reported hazard: The affected products have approximately a 91% specificity while the non-affected lots have approximately a 99% specificity. The recalling firm is aware of three customers who reported false positive results.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail